As Stacey Leasca reports for “Food & Wine,” research from Cornell University found that households with at least one GLP-1 ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

The digital pharmacy startup priced its oral medication kits at $79 per month, while its compounded GLP-1 injections go for $199 per month. In November, the company launched a GLP-1 tracker amid ...

These medications are administered subcutaneously with the assistance of injection pens. To ensure market exclusivity, Novo Nordisk and Eli Lilly have secured patents for these drugs worldwide.

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

With one in eight Americans having taken a GLP-1 already — including 43% of those ... around issues such as expected results, proper injection technique, recognising and managing side effects ...

Yorvipath cuts the number of daily injections needed to treat hypoparathyroidism ... allowing it to tap into the burgeoning market for GLP-1 therapies for diabetes, obesity, and other associated ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...